Asiatic Laboratories Limited (DSE:ASIATICLAB)
68.40
+0.70 (1.03%)
At close: Feb 10, 2026
Asiatic Laboratories Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 18.72 | 17.73 | 159.42 | 446.74 | 7.89 | 8.98 |
Cash & Short-Term Investments | 18.72 | 17.73 | 159.42 | 446.74 | 7.89 | 8.98 |
Cash Growth | 137.32% | -88.88% | -64.32% | 5563.60% | -12.20% | -20.26% |
Receivables | 681.76 | 649.64 | 401.76 | 372.02 | 278.02 | 192.2 |
Inventory | 669.13 | 636.44 | 476.74 | 341.11 | 376 | 319.94 |
Other Current Assets | 809.62 | 798.83 | 617.71 | 126.71 | 186.13 | 109.52 |
Total Current Assets | 2,179 | 2,103 | 1,656 | 1,287 | 848.03 | 630.64 |
Property, Plant & Equipment | 6,962 | 6,762 | 5,765 | 5,636 | 5,410 | 5,230 |
Other Intangible Assets | 0.67 | 0.79 | 1.29 | 1.79 | 2.29 | 2.79 |
Other Long-Term Assets | -0 | -0 | - | - | 0 | - |
Total Assets | 9,142 | 8,866 | 7,422 | 6,924 | 6,260 | 5,864 |
Accounts Payable | 10.79 | 6.96 | 8.76 | 7.47 | 16.73 | 15.21 |
Accrued Expenses | 61.91 | 49.13 | 59.12 | 38.34 | 39.65 | 34.91 |
Short-Term Debt | 66.39 | 63.7 | 49.85 | 51.75 | 8.88 | 9.43 |
Current Portion of Long-Term Debt | 271.08 | 260.73 | 17.19 | 58.54 | 78.43 | 83.15 |
Current Portion of Leases | 17.04 | 15.76 | 11.15 | 12.19 | 21.44 | 16.72 |
Current Income Taxes Payable | 151.81 | 105.31 | 101.8 | 112.35 | 145.45 | 71.71 |
Other Current Liabilities | 13.18 | 13.22 | - | -0 | 0 | - |
Total Current Liabilities | 592.18 | 514.82 | 247.86 | 280.64 | 310.57 | 231.11 |
Long-Term Debt | 1,082 | 1,041 | 69.44 | 274.73 | 240.46 | 225.89 |
Long-Term Leases | 38.7 | 31.17 | 37.44 | 47.13 | 32.76 | 32.62 |
Long-Term Deferred Tax Liabilities | 657.17 | 659.38 | 631.79 | 657.46 | 433.03 | 401.04 |
Other Long-Term Liabilities | 0 | - | -0 | - | 0 | - |
Total Liabilities | 2,370 | 2,246 | 986.53 | 1,260 | 1,017 | 890.66 |
Common Stock | 1,224 | 1,224 | 1,224 | 878.48 | 878.48 | 878.48 |
Additional Paid-In Capital | 578.23 | 578.23 | 578.23 | - | - | - |
Retained Earnings | 3,351 | 3,197 | 3,009 | 2,725 | 2,514 | 2,239 |
Comprehensive Income & Other | 1,619 | 1,620 | 1,624 | 2,060 | 1,851 | 1,856 |
Shareholders' Equity | 6,772 | 6,619 | 6,436 | 5,664 | 5,243 | 4,973 |
Total Liabilities & Equity | 9,142 | 8,866 | 7,422 | 6,924 | 6,260 | 5,864 |
Total Debt | 1,476 | 1,412 | 185.06 | 444.35 | 381.96 | 367.8 |
Net Cash (Debt) | -1,457 | -1,394 | -25.65 | 2.4 | -374.08 | -358.81 |
Net Cash Per Share | -11.90 | -11.39 | -0.26 | 0.03 | -4.26 | -4.08 |
Filing Date Shares Outstanding | 122.39 | 122.39 | 122.39 | 87.85 | 87.85 | 87.85 |
Total Common Shares Outstanding | 122.39 | 122.39 | 122.39 | 87.85 | 87.85 | 87.85 |
Working Capital | 1,587 | 1,588 | 1,408 | 1,006 | 537.46 | 399.53 |
Book Value Per Share | 55.33 | 54.08 | 52.58 | 64.48 | 59.68 | 56.61 |
Tangible Book Value | 6,771 | 6,618 | 6,434 | 5,662 | 5,241 | 4,970 |
Tangible Book Value Per Share | 55.32 | 54.08 | 52.57 | 64.46 | 59.66 | 56.58 |
Land | - | - | 3,160 | - | - | 3,139 |
Buildings | - | - | 1,213 | - | - | 1,189 |
Machinery | - | - | 2,247 | - | - | 1,377 |
Construction In Progress | - | 297.67 | 42.09 | 78.14 | 41.32 | 46.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.